Intranasal Steroids and the Nasal Ocular Response
NCT00473915 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2013-06-03
Summary
Eye symptoms of tearing, redness and itch frequently occur in patients with allergic rhinitis or hayfever. The purpose of this study is to learn whether placing allergen (the substance that causes allergies) in the nose several days in a row will cause an increase in eye symptoms and whether receiving a nasal steroid spray will prevent these eye symptoms.
Conditions
- Seasonal Allergic Rhinitis
Interventions
- DRUG
-
fluticasone furoate
corticosteroid nasal spray
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of Chicago
lead OTHER
Principal Investigators
-
Robert m Naclerio, MD · University of Chicago
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-04-30
- Primary Completion
- 2007-12-31
- Completion
- 2008-02-29
Countries
- United States
Study Locations
More Related Trials
-
Patient Preference Study of Fluticasone Furoate and Mometasone Furoate Nasal Sprays
NCT02397915 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis
NCT00609674 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Fluticasone Propionate on Ocular Allergy Symptoms
NCT01817790 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis
NCT00730756 ·Status: COMPLETED ·Phase: PHASE2
-
Concomitant Intranasal Antihistamine and Corticosteroid in Stepwise Treatment Strategy for Allergic Rhinitis
NCT05708157 ·Status: UNKNOWN
-
Single and Repeat Dose First Time in Human Study for an Intranasal H1/H3 Dual Antagonist in Healthy Male Subjects
NCT00694993 ·Status: COMPLETED ·Phase: PHASE1
-
Effects Of Single Doses Of GW784568X On Allergic Rhinitis Symptoms In Male Subjects Whilst In An Environmental Chamber
NCT00404586 ·Status: COMPLETED ·Phase: PHASE1
-
A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
NCT00953147 ·Status: COMPLETED ·Phase: PHASE3
-
Study In Adults And Adolescents With Seasonal Allergic Rhinitis
NCT00115622 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270)
NCT00834119 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Intranasal Corticosteroids on Systemic Allergen Specific IgE
NCT00755066 ·Status: COMPLETED ·Phase: NA
-
Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid
NCT00845195 ·Status: COMPLETED ·Phase: PHASE4
-
Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge
NCT01657097 ·Status: COMPLETED ·Phase: PHASE4
-
Fluticasone Nasal Spray Patient Preference Study
NCT00398476 ·Status: COMPLETED ·Phase: PHASE3
-
Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS
NCT00539006 ·Status: COMPLETED ·Phase: PHASE4
-
Flixonase Safety in Patients With Allergic Rhinitis (AR)
NCT01077609 ·Status: COMPLETED
-
Effectiveness of Oxymetazoline Added on Nasal Steroid in Rhinitis With Persistent Nasal Obstruction
NCT01847131 ·Status: COMPLETED ·Phase: PHASE4
-
Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)
NCT00348361 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis
NCT01287364 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
NCT00740792 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Observational Study of Concomitant Allergic Rhinitis Treatment Patterns Among Patients Starting on Fluticasone Furoate Nasal Spray in a Retail Pharmacy Setting
NCT01337323 ·Status: TERMINATED
-
Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)
NCT00806754 ·Status: COMPLETED ·Phase: PHASE4
-
Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine
NCT00435461 ·Status: COMPLETED ·Phase: PHASE4
-
Airway Inflammation in Children With Allergic Rhinitis and Intervention
NCT02352168 ·Status: COMPLETED ·Phase: NA
-
Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)
NCT03882047 ·Status: COMPLETED ·Phase: PHASE3